358 related articles for article (PubMed ID: 28473983)
1. Microglia-Synapse Pathways: Promising Therapeutic Strategy for Alzheimer's Disease.
Xie J; Wang H; Lin T; Bi B
Biomed Res Int; 2017; 2017():2986460. PubMed ID: 28473983
[TBL] [Abstract][Full Text] [Related]
2. Microglia in Alzheimer's Disease.
Süß P; Schlachetzki JCM
Curr Alzheimer Res; 2020; 17(1):29-43. PubMed ID: 32048973
[TBL] [Abstract][Full Text] [Related]
3. Microglia contributes to plaque growth by cell death due to uptake of amyloid β in the brain of Alzheimer's disease mouse model.
Baik SH; Kang S; Son SM; Mook-Jung I
Glia; 2016 Dec; 64(12):2274-2290. PubMed ID: 27658617
[TBL] [Abstract][Full Text] [Related]
4. Human tau increases amyloid β plaque size but not amyloid β-mediated synapse loss in a novel mouse model of Alzheimer's disease.
Jackson RJ; Rudinskiy N; Herrmann AG; Croft S; Kim JM; Petrova V; Ramos-Rodriguez JJ; Pitstick R; Wegmann S; Garcia-Alloza M; Carlson GA; Hyman BT; Spires-Jones TL
Eur J Neurosci; 2016 Dec; 44(12):3056-3066. PubMed ID: 27748574
[TBL] [Abstract][Full Text] [Related]
5. Molecular and Cellular Basis of Neurodegeneration in Alzheimer's Disease.
Jeong S
Mol Cells; 2017 Sep; 40(9):613-620. PubMed ID: 28927263
[TBL] [Abstract][Full Text] [Related]
6. Synaptic Mitochondria: An Early Target of Amyloid-β and Tau in Alzheimer's Disease.
Torres AK; Jara C; Park-Kang HS; Polanco CM; Tapia D; Alarcón F; de la Peña A; Llanquinao J; Vargas-Mardones G; Indo JA; Inestrosa NC; Tapia-Rojas C
J Alzheimers Dis; 2021; 84(4):1391-1414. PubMed ID: 34719499
[TBL] [Abstract][Full Text] [Related]
7. Zinc utilization by microglia in Alzheimer's disease.
Shippy DC; Oliai SF; Ulland TK
J Biol Chem; 2024 May; 300(5):107306. PubMed ID: 38648940
[TBL] [Abstract][Full Text] [Related]
8. Microglia-mediated T cell infiltration drives neurodegeneration in tauopathy.
Chen X; Firulyova M; Manis M; Herz J; Smirnov I; Aladyeva E; Wang C; Bao X; Finn MB; Hu H; Shchukina I; Kim MW; Yuede CM; Kipnis J; Artyomov MN; Ulrich JD; Holtzman DM
Nature; 2023 Mar; 615(7953):668-677. PubMed ID: 36890231
[TBL] [Abstract][Full Text] [Related]
9. The intersection of amyloid beta and tau at synapses in Alzheimer's disease.
Spires-Jones TL; Hyman BT
Neuron; 2014 May; 82(4):756-71. PubMed ID: 24853936
[TBL] [Abstract][Full Text] [Related]
10. Anti-Aβ antibodies bound to neuritic plaques enhance microglia activity and mitigate tau pathology.
Laversenne V; Nazeeruddin S; Källstig EC; Colin P; Voize C; Schneider BL
Acta Neuropathol Commun; 2020 Nov; 8(1):198. PubMed ID: 33225991
[TBL] [Abstract][Full Text] [Related]
11. Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology.
Perez-Nievas BG; Stein TD; Tai HC; Dols-Icardo O; Scotton TC; Barroeta-Espar I; Fernandez-Carballo L; de Munain EL; Perez J; Marquie M; Serrano-Pozo A; Frosch MP; Lowe V; Parisi JE; Petersen RC; Ikonomovic MD; López OL; Klunk W; Hyman BT; Gómez-Isla T
Brain; 2013 Aug; 136(Pt 8):2510-26. PubMed ID: 23824488
[TBL] [Abstract][Full Text] [Related]
12. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
Elife; 2020 Jun; 9():. PubMed ID: 32510331
[TBL] [Abstract][Full Text] [Related]
13. Transposable elements and Alzheimer's disease pathogenesis.
Evering TH; Marston JL; Gan L; Nixon DF
Trends Neurosci; 2023 Mar; 46(3):170-172. PubMed ID: 36588011
[TBL] [Abstract][Full Text] [Related]
14. CSF1R inhibition rescues tau pathology and neurodegeneration in an A/T/N model with combined AD pathologies, while preserving plaque associated microglia.
Lodder C; Scheyltjens I; Stancu IC; Botella Lucena P; Gutiérrez de Ravé M; Vanherle S; Vanmierlo T; Cremers N; Vanrusselt H; Brône B; Hanseeuw B; Octave JN; Bottelbergs A; Movahedi K; Dewachter I
Acta Neuropathol Commun; 2021 Jun; 9(1):108. PubMed ID: 34103079
[TBL] [Abstract][Full Text] [Related]
15. Increased tauopathy drives microglia-mediated clearance of beta-amyloid.
Chen W; Abud EA; Yeung ST; Lakatos A; Nassi T; Wang J; Blum D; Buée L; Poon WW; Blurton-Jones M
Acta Neuropathol Commun; 2016 Jun; 4(1):63. PubMed ID: 27339073
[TBL] [Abstract][Full Text] [Related]
16. The fluorescent ligand bTVBT2 reveals increased p-tau uptake by retinal microglia in Alzheimer's disease patients and App
Nuñez-Diaz C; Andersson E; Schultz N; Pocevičiūtė D; Hansson O; ; Nilsson KPR; Wennström M
Alzheimers Res Ther; 2024 Jan; 16(1):4. PubMed ID: 38167557
[TBL] [Abstract][Full Text] [Related]
17. Distinct amyloid-β and tau-associated microglia profiles in Alzheimer's disease.
Gerrits E; Brouwer N; Kooistra SM; Woodbury ME; Vermeiren Y; Lambourne M; Mulder J; Kummer M; Möller T; Biber K; Dunnen WFAD; De Deyn PP; Eggen BJL; Boddeke EWGM
Acta Neuropathol; 2021 May; 141(5):681-696. PubMed ID: 33609158
[TBL] [Abstract][Full Text] [Related]
18. Microglia and amyloid plaque formation in Alzheimer's disease - Evidence, possible mechanisms, and future challenges.
Fruhwürth S; Zetterberg H; Paludan SR
J Neuroimmunol; 2024 May; 390():578342. PubMed ID: 38640827
[TBL] [Abstract][Full Text] [Related]
19. Twenty Years of Presenilins--Important Proteins in Health and Disease.
Walter J
Mol Med; 2015 Oct; 21 Suppl 1(Suppl 1):S41-8. PubMed ID: 26605647
[TBL] [Abstract][Full Text] [Related]
20. Tau Oligomer-Containing Synapse Elimination by Microglia and Astrocytes in Alzheimer Disease.
Taddei RN; Perbet R; Mate de Gerando A; Wiedmer AE; Sanchez-Mico M; Connors Stewart T; Gaona A; Melloni A; Amaral AC; Duff K; Frosch MP; Gómez-Isla T
JAMA Neurol; 2023 Nov; 80(11):1209-1221. PubMed ID: 37812432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]